CRVS Corvus Pharmaceuticals, Inc. - Common Stock
CRVS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
CRVS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
CRVS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 5 35,7%
- Al 8 57,1%
- Tut 1 7,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
7 analist · 2026-08-16Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.19 | $-0.16 | -0.03% |
| 31 Mart 2026 | $-0.15 | $-0.15 | -0.00% |
| 31 Aralık 2025 | $-0.15 | $-0.13 | -0.02% |
| 30 Eylül 2025 | $-0.12 | $-0.14 | 0.02% |
| 30 Haziran 2025 | $-0.10 | $-0.14 | 0.04% |
| 31 Mart 2025 | $0.21 | $-0.12 | 0.33% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $34M | $19M | $17M | $24M | $29M | $32M | $38M | $39M | $46M | $29M | $11M | |
| SG&A Expense | $9M | $8M | $7M | $8M | $10M | $12M | $11M | $11M | $10M | $8M | $2M | |
| Operating Expenses | $43M | $28M | $23M | $33M | $39M | $44M | $49M | $49M | $57M | $37M | $14M | |
| Operating Income | $-43M | $-28M | $-23M | $-33M | $-39M | $-44M | $-49M | $-49M | $-57M | $-37M | $-14M | |
| Pretax Income | $-13M | $-59M | $-22M | $-31M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| EPS (Basic) | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| Shares (Basic) | 78,964,842 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| Shares (Diluted) | 79,742,685 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| EBITDA | $-43M | $-27M | $-23M | $-32M | $-38M | $-43M | $-48M | $-48M | · | · | · |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $13M | $13M | $63M | $16M | $5M | $39M | $45M | $5M | $4M | |
| Receivables | $37.0K | $75.0K | $26.0K | $588.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $781.0K | $773.0K | $1M | $1M | $1M | $992.0K | $1M | $1M | $1M | |
| Other Current Assets | $353.0K | $548.0K | $220.0K | $102.0K | $128.0K | $406.0K | $486.0K | $265.0K | $412.0K | $772.0K | $208.0K | |
| Current Assets | $58M | $54M | $28M | $44M | $71M | $45M | $79M | $116M | $91M | $136M | $96M | |
| PP&E (Net) | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1M | $2M | $3M | $3M | $2M | |
| PP&E (Gross) | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $729.0K | $135.0K | |
| Other Non-current Assets | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | · | |
| Total Assets | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $6M | $4M | $4M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $35M | $7M | $11M | $10M | $12M | $10M | $7M | $9M | $6M | $3M | |
| Capital Leases | $534.0K | $937.0K | · | $1M | $3M | $1M | $2M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $869.0K | $971.0K | $1M | $710.0K | |
| Total Liabilities | $10M | $36M | $7M | $12M | $12M | $13M | $13M | $8M | $10M | $7M | $4M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $474M | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-412M | $-397M | $-335M | $-308M | $-266M | $-223M | $-217M | $-170M | $-124M | $-68M | $-31M | |
| AOCI | $-896.0K | $-1M | $-967.0K | $-563.0K | $2M | $4.0K | $29.0K | $-34.0K | $-41.0K | $-39.0K | $-45.0K | |
| Stockholders' Equity | $61M | $33M | $39M | $56M | $97M | $72M | $71M | $110M | $85M | $133M | $-31M | |
| Liabilities + Equity | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Shares Outstanding | 74,696,629 | 67,899,779 | 49,038,582 | 46,553,511 | 46,553,511 | 28,372,634 | 27,953,233 | 29,323,930 | 21,041,250 | 20,922,428 | 1,431,615 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $4M | $6M | $7M | $7M | $6M | $4M | $428.0K | |
| Other Non-cash | $-23M | $34M | $796.0K | $11M | $2M | $-35M | $1M | $-2M | · | · | · | |
| Operating Cash Flow | $-33M | $-25M | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | $-46M | $-28M | $-11M | |
| CapEx | $174.0K | · | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2M | $2M | |
| Investing Cash Flow | $-8M | $-27M | $16M | $-23M | $22M | $45M | $3M | $-30M | $85M | $-43M | $-92M | |
| Stock Issued | · | $16M | · | · | $32M | · | · | $65M | $711.0K | $71M | · | |
| Net Stock Activity | · | $16M | · | · | $32M | · | · | $65M | · | · | · | |
| Financing Cash Flow | $36M | $49M | $8M | $0 | $62M | $1M | $24.0K | $65M | $1M | $71M | $95M | |
| Net Change in Cash | $-4M | $-4M | $-539.0K | $-50M | $47M | $11M | $-34M | $-6M | $40M | $945.0K | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | · | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | · | · | · |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | -108.9% | -47.5% | -46.5% | -44.4% | -7.1% | -46.2% | -44.1% | · | · | · | |
| ROE | -21.6% | -277.0% | -65.1% | -68.4% | -42.8% | -10.5% | -61.6% | -41.0% | · | · | · | |
| ROIC | -70.2% | -84.6% | -60.5% | -58.0% | -39.8% | -60.7% | -68.7% | -44.6% | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 | 3.7 | 7.8 | 16.4 | · | · | · | |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 | 1.4 | 0.5 | 5.6 | · | · | · |
Değerleme (TTM) 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | · | |
| Market Cap | $575M | $363M | $86M | $40M | $112M | $101M | $152M | $108M | · | · | · | |
| P/E | -14.5 | -5.2 | -3.1 | -1.0 | -2.3 | -17.8 | -3.4 | · | · | · | · | |
| P/B | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | 2.1 | 1.0 | · | · | · | |
| P / Tangible Book | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | · | · | · | · | · | |
| P / Cash Flow | -17.5 | -14.3 | -3.6 | -1.5 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| P / FCF | -17.4 | · | -3.6 | -1.4 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| Earnings Yield | -6.9% | -19.1% | -31.8% | -104.7% | -42.7% | -5.6% | -29.2% | · | · | · | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $16M | $11M | $10M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $10M | $5M | |
| SG&A Expense | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $19M | $15M | $12M | $11M | $10M | $10M | $8M | $7M | $6M | $6M | $6M | $6M | $6M | $7M | $12M | $7M | |
| Operating Income | $-19M | $-15M | $-12M | $-11M | $-10M | $-10M | $-8M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | |
| Other Non-op | · | $1M | · | $415.0K | $2M | $25M | · | $-33M | $2M | $-552.0K | · | · | · | · | · | · | |
| Pretax Income | $-17M | $-13M | $-12M | $-10M | $-8M | $16M | $-10M | $-40M | $-4M | $-6M | $-5M | $-5M | $-5M | $-6M | · | · | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-18M | $-14M | $-12M | $-10M | $-8M | $15M | $-12M | $-40M | $-4M | $-6M | $-7M | $-6M | $-7M | $-8M | $-15M | $-8M | |
| EPS (Basic) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $0.21 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | |
| EPS (Diluted) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $-0.13 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | |
| Shares (Basic) | 92,368,013 | 89,996,728 | -153,772,367 | 82,836,369 | 77,774,344 | 72,126,496 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | |
| Shares (Diluted) | 92,368,013 | 89,996,728 | -156,020,542 | 82,836,369 | 77,774,344 | 75,152,514 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | |
| EBITDA | $-19M | $-15M | · | $-11M | $-10M | $-10M | · | $-7M | $-6M | $-6M | · | $-6M | $-6M | $-7M | $-12M | $-7M |
Bilanço 22
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $40M | $5M | $3M | $15M | $5M | $9M | $5M | $15M | $7M | · | $20M | $8M | $10M | $25M | $28M | |
| Receivables | $6.0K | $43.0K | $37.0K | $32.0K | $86.0K | $79.0K | $75.0K | $70.0K | $35.0K | $26.0K | · | $11.0K | · | · | · | · | |
| Prepaid Expense | $6M | $3M | $1M | $1M | $1M | $1M | $2M | $1M | $977.0K | $697.0K | · | $915.0K | $893.0K | $655.0K | $1M | $2M | |
| Other Current Assets | $575.0K | $367.0K | $318.0K | $509.0K | $569.0K | $458.0K | $548.0K | $633.0K | $240.0K | $267.0K | · | $214.0K | $136.0K | $131.0K | $397.0K | $395.0K | |
| Current Assets | $221M | $240M | $58M | $67M | $76M | $45M | $54M | $43M | $48M | $23M | · | $33M | $38M | $36M | $51M | $59M | |
| PP&E (Net) | $830.0K | $282.0K | $220.0K | $221.0K | $249.0K | $165.0K | $151.0K | $171.0K | $192.0K | $213.0K | · | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | |
| PP&E (Gross) | $4M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $855.0K | $852.0K | $626.0K | $629.0K | $632.0K | $252.0K | $129.0K | $89.0K | · | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | |
| Total Assets | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | |
| Accounts Payable | $4M | $5M | $2M | $2M | $3M | $1M | $3M | $2M | $1M | $2M | · | $1M | $2M | $1M | $4M | $3M | |
| Accrued Liabilities | $9M | $7M | $6M | $6M | $5M | $4M | $4M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $12M | $9M | $8M | $9M | $9M | $35M | $46M | $13M | $7M | · | $7M | $8M | $8M | $14M | $10M | |
| Capital Leases | $274.0K | $406.0K | $534.0K | $632.0K | $728.0K | $834.0K | $937.0K | · | · | · | · | $354.0K | $700.0K | $1M | $2M | $2M | |
| Total Liabilities | $14M | $13M | $10M | $9M | $9M | $10M | $36M | $46M | $13M | $7M | · | $8M | $9M | $9M | $16M | $12M | |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $671M | $668M | $474M | · | · | · | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-444M | $-426M | $-412M | $-400M | $-390M | $-382M | $-397M | $-385M | $-345M | $-340M | · | $-328M | $-322M | $-316M | $-298M | $-283M | |
| AOCI | $-1M | $-1M | $-896.0K | $-1M | $-1M | $-1M | $-1M | $-738.0K | $-1M | $-1M | · | $-1M | $-1M | $-434.0K | $-1M | $339.0K | |
| Stockholders' Equity | $225M | $241M | $61M | $72M | $80M | $49M | $33M | $12M | $51M | $33M | $39M | $44M | $49M | $49M | $65M | $80M | |
| Liabilities + Equity | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | |
| Shares Outstanding | 84,120,944 | 84,090,424 | 74,696,629 | 74,681,872 | 74,514,039 | 68,169,461 | 67,899,779 | 62,580,031 | 62,551,281 | 49,038,582 | · | 49,038,582 | 48,898,362 | 46,568,511 | 46,553,511 | 46,553,511 |
Nakit Akışı 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $29.0K | $26.0K | $28.0K | $29.0K | $22.0K | $20.0K | $21.0K | $21.0K | $23.0K | $28.0K | $30.0K | $36.0K | $57.0K | $94.0K | $92.0K | |
| Stock-based Comp | $3M | $3M | $2M | $1M | $1M | $1M | $813.0K | $733.0K | $768.0K | $689.0K | $572.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | |
| Other Non-cash | · | $639.0K | · | · | · | $-25M | · | · | · | $-168.0K | · | · | · | $-787.0K | · | · | |
| Operating Cash Flow | $-15M | $-10M | $-9M | $-10M | $-6M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $-7M | $-6M | |
| CapEx | $582.0K | $91.0K | $25.0K | $0 | $113.0K | $36.0K | · | · | · | · | $0 | $0 | $0 | $34.0K | $265.0K | · | |
| Investing Cash Flow | $-6M | $-145M | $11M | $-3M | $-20M | $4M | $-6M | $-4M | $-18M | $-7.0K | $-2M | $18M | $-4M | $5M | $3M | $3M | |
| Stock Issued | $0 | $189M | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $189M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $166.0K | $191M | $20.0K | $360.0K | $36M | $279.0K | $19M | $50.0K | · | · | $0 | $335.0K | $8M | $4.0K | · | · | |
| Net Change in Cash | $-21M | $36M | $2M | $-12M | $10M | $-4M | $4M | $-10M | $7M | $-5M | $-7M | $12M | $-2M | $-4M | $-4M | $-3M | |
| Free Cash Flow | · | $-10M | · | · | · | $-8M | · | · | · | · | · | · | · | $-8M | · | · |
Kârlılık 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | -8.8% | · | -14.6% | -10.4% | 30.5% | · | -72.6% | -7.0% | -11.6% | · | -9.1% | -8.6% | -9.9% | -14.9% | -8.3% | |
| ROE | -11.8% | -9.4% | · | -24.1% | -12.2% | 36.8% | · | -141.9% | -8.5% | -13.9% | · | -11.0% | -10.0% | -11.4% | -17.5% | -9.5% | |
| ROIC | · | -6.2% | · | · | · | · | · | · | · | -18.7% | · | · | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.2 | 19.8 | · | 8.3 | 8.9 | 4.9 | · | 0.9 | 3.6 | 3.4 | · | 4.5 | 4.8 | 4.3 | 3.7 | 5.8 | |
| Quick Ratio | 1.4 | 3.3 | · | 0.4 | 1.7 | 0.5 | · | 0.1 | 1.1 | 1.1 | · | 2.8 | 1.0 | 1.2 | 1.8 | 2.8 |
Değerleme (TTM) 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-50M | $-17M | · | $-43M | $-37M | $-35M | · | $-56M | $-22M | $-26M | · | $-35M | $-38M | $-39M | $-42M | $-39M | |
| Market Cap | $1.26B | $1.23B | · | $550M | $298M | $217M | · | $330M | $114M | $87M | · | $72M | $112M | $42M | $38M | $46M | |
| P/E | -26.7 | -29.3 | · | -7.8 | -4.4 | -3.5 | · | -5.8 | -4.0 | -3.2 | · | -1.9 | -2.8 | -1.1 | -0.9 | -1.2 | |
| P/B | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | |
| P / Tangible Book | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | |
| P / Cash Flow | · | -118.6 | · | · | · | -26.2 | · | · | · | -16.9 | · | · | · | -5.2 | · | · | |
| P / FCF | · | -117.6 | · | · | · | -26.1 | · | · | · | · | · | · | · | -5.2 | · | · | |
| Earnings Yield | -3.8% | -3.4% | · | -12.9% | -22.5% | -28.9% | · | -17.2% | -24.7% | -30.9% | · | -51.4% | -35.4% | -93.4% | -107.5% | -80.8% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-15M | $-62M | $-27M | $-41M | $-43M |
| Seyreltilmiş Hisse Başı Kâr | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 |
| Cari Oran | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-33M | — | $-24M | $-27M | $-37M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 189 dosya · $850.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 47 (-18 önceki Ç'ye göre) | 28 (+7 önceki Ç'ye göre) | 68 (+9 önceki Ç'ye göre) | 40 (+13 önceki Ç'ye göre) | +7.8M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $107.045.190 | 7.165.006 | 12,59% | Hisse senetleri |
| STATE STREET CORP | $66.842.920 | 4.474.091 | 7,86% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.193.087 | 3.292.710 | 5,78% | Hisse senetleri |
| ADAMS STREET PARTNERS LLC | $48.937.703 | 3.275.616 | 5,75% | Hisse senetleri |
| Vivo Capital, LLC | $41.918.891 | 2.805.816 | 4,93% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $39.851.569 | 2.667.441 | 4,69% | Hisse senetleri |
| Deep Track Capital, LP | $37.229.569 | 2.491.939 | 4,38% | Hisse senetleri |
| BRAIDWELL LP | $31.766.892 | 2.126.298 | 3,74% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $28.099.301 | 1.880.810 | 3,30% | Hisse senetleri |
| Foresite Capital Management VI LLC | $27.358.621 | 1.831.233 | 3,22% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $23.775.864 | 1.590.939 | 2,80% | Hisse senetleri |
| Hood River Capital Management LLC | $23.482.767 | 1.571.805 | 2,76% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $19.824.246 | 1.326.924 | 2,33% | Hisse senetleri |
| Boxer Capital Management, LLC | $16.434.000 | 1.100.000 | 1,93% | Hisse senetleri |
| Catalio Capital Management, LP | $16.148.467 | 1.080.888 | 1,90% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $15.656.896 | 1.047.985 | 1,84% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.172.365 | 814.750 | 1,43% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $11.731.008 | 785.208 | 1,38% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.205.000 | 750.000 | 1,32% | Hisse senetleri |
| Eversept Partners, LP | $11.175.030 | 747.994 | 1,31% | Hisse senetleri |
| EMERALD ADVISERS, LLC | $10.244.104 | 685.683 | 1,20% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $10.073.400 | 674.257 | 1,18% | Hisse senetleri |
| DCF Advisers, LLC | $9.524.250 | 637.500 | 1,12% | Hisse senetleri |
| Blue Owl Capital Holdings LP | $9.092.484 | 608.600 | 1,07% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.739.900 | 585.000 | 1,03% | Alım opsiyonu |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7.864.252 | 526.389 | 0,92% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $7.776.688 | 520.528 | 0,91% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $6.723.000 | 450.000 | 0,79% | Hisse senetleri |
| Nextech Invest Ltd. | $6.723.000 | 450.000 | 0,79% | Hisse senetleri |
| CITADEL ADVISORS LLC | $6.675.192 | 446.800 | 0,78% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $5.945.388 | 397.951 | 0,70% | Hisse senetleri |
| Jump Financial, LLC | $4.682.196 | 313.400 | 0,55% | Hisse senetleri |
| BARCLAYS PLC | $4.589.313 | 307.183 | 0,54% | Hisse senetleri |
| Trexquant Investment LP | $4.427.424 | 296.347 | 0,52% | Hisse senetleri |
| DIADEMA PARTNERS LP | $4.404.476 | 294.811 | 0,52% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.101.030 | 274.500 | 0,48% | Satım opsiyonu |
| Polymer Capital Management (HK) LTD | $3.939.110 | 263.662 | 0,46% | Hisse senetleri |
| Brevan Howard Capital Management LP | $3.739.348 | 250.291 | 0,44% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $3.659.717 | 244.961 | 0,43% | Hisse senetleri |
| Spruce Street Capital LP | $3.459.880 | 231.585 | 0,41% | Hisse senetleri |
| SEB Asset Management AB | $3.388.938 | 226.837 | 0,40% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $3.298.169 | 220.761 | 0,39% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $3.253.185 | 217.750 | 0,38% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.109.298 | 208.119 | 0,37% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.959.614 | 198.100 | 0,35% | Satım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.848.177 | 190.641 | 0,33% | Hisse senetleri |
| Caption Management, LLC | $2.838.600 | 190.000 | 0,33% | Alım opsiyonu |
| F/m Investments LLC | $2.497.445 | 167.165 | 0,29% | Hisse senetleri |
| JANE STREET GROUP, LLC | $2.094.588 | 140.200 | 0,25% | Alım opsiyonu |
| BlackRock, Inc. | $2.085.251 | 139.575 | 0,25% | Hisse senetleri |
| DIADEMA PARTNERS LP | $1.992.996 | 133.400 | 0,23% | Alım opsiyonu |
| Swiss National Bank | $1.889.910 | 126.500 | 0,22% | Hisse senetleri |
| Aquatic Capital Management LLC | $1.762.920 | 118.000 | 0,21% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $1.749.489 | 117.101 | 0,21% | Hisse senetleri |
| CITIGROUP INC | $1.664.555 | 111.416 | 0,20% | Hisse senetleri |
| Caption Management, LLC | $1.664.316 | 111.400 | 0,20% | Satım opsiyonu |
| MARSHALL WACE, LLP | $1.501.082 | 100.474 | 0,18% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $1.379.604 | 92.343 | 0,16% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $1.322.845 | 90.420 | 0,16% | Hisse senetleri |
| RHUMBLINE ADVISERS | $1.285.128 | 86.020 | 0,15% | Hisse senetleri |
| ALPS ADVISORS INC | $1.274.980 | 85.340 | 0,15% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.238.631 | 82.907 | 0,15% | Hisse senetleri |
| Seven Fleet Capital Management LP | $1.238.377 | 82.890 | 0,15% | Hisse senetleri |
| TD Asset Management Inc | $1.233.984 | 82.596 | 0,15% | Hisse senetleri |
| Rafferty Asset Management, LLC | $1.217.520 | 81.494 | 0,14% | Hisse senetleri |
| SEI INVESTMENTS CO | $1.195.290 | 80.006 | 0,14% | Hisse senetleri |
| Avidity Partners Management LP | $1.195.200 | 80.000 | 0,14% | Hisse senetleri |
| Persistent Asset Partners Ltd | $1.117.452 | 74.796 | 0,13% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.094.011 | 73.227 | 0,13% | Hisse senetleri |
| Propel Bio Management, LLC | $1.051.477 | 70.380 | 0,12% | Hisse senetleri |
| TOWERVIEW LLC | $1.045.800 | 70.000 | 0,12% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $967.768 | 64.777 | 0,11% | Hisse senetleri |
| Caption Management, LLC | $956.668 | 64.034 | 0,11% | Hisse senetleri |
| JACKSON SQUARE CAPITAL, LLC | $952.769 | 63.773 | 0,11% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $920.155 | 61.590 | 0,11% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $902.376 | 60.400 | 0,11% | Alım opsiyonu |
| Ancora Advisors LLC | $847.442 | 56.723 | 0,10% | Hisse senetleri |
| SEVEN GRAND MANAGERS, LLC | $747.000 | 50.000 | 0,09% | Hisse senetleri |
| GROUP ONE TRADING LLC | $721.482 | 48.292 | 0,08% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $712.459 | 47.688 | 0,08% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $660.632 | 44.219 | 0,08% | Hisse senetleri |
| Squarepoint Ops LLC | $660.423 | 44.205 | 0,08% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $653.909 | 43.769 | 0,08% | Hisse senetleri |
| TEMA ETFS LLC | $613.675 | 79.698 | 0,07% | Hisse senetleri |
| PROFUND ADVISORS LLC | $613.197 | 41.044 | 0,07% | Hisse senetleri |
| MetLife Investment Management, LLC | $592.341 | 39.648 | 0,07% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $559.159 | 37.427 | 0,07% | Hisse senetleri |
| AVITY INVESTMENT MANAGEMENT INC. | $555.021 | 37.150 | 0,07% | Hisse senetleri |
| Engineers Gate Manager LP | $538.124 | 36.019 | 0,06% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $494.365 | 33.090 | 0,06% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $414.719 | 27.759 | 0,05% | Hisse senetleri |
| Optimize Financial Inc | $410.518 | 28.060 | 0,05% | Hisse senetleri |
| Virtus Investment Advisers, LLC | $409.759 | 27.427 | 0,05% | Hisse senetleri |
| ACT CAPITAL MANAGEMENT, LLC | $403.380 | 27.000 | 0,05% | Hisse senetleri |
| Invesco Ltd. | $402.917 | 26.969 | 0,05% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $374.994 | 25.100 | 0,04% | Hisse senetleri |
| SIMON QUICK ADVISORS, LLC | $373.500 | 25.000 | 0,04% | Hisse senetleri |
| PEAK6 LLC | $352.584 | 23.600 | 0,04% | Alım opsiyonu |
| WINTON GROUP Ltd | $346.608 | 23.200 | 0,04% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $328.560 | 21.992 | 0,04% | Hisse senetleri |
Şirket yöneticileri 19 içeriden öğrenenler · 8 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Richard A Miller MD | President and CEO | 31 Mart 2023 A | 1.163.507 | 0 | 0 | $0 |
| Leiv Lea | Chief Financial Officer | 21 Aralık 2018 P | 24.700 | 0 | 0 | $0 |
| Mehrdad Mobasher | Chief Medical Officer | 28 Ocak 2019 A | — | 0 | 0 | $0 |
| Daniel W. Hunt | SVP, Chief Business Officer | 12 Aralık 2018 A | — | 0 | 0 | $0 |
| William Benton Jones | SVP, Pharmaceutical Development | 12 Aralık 2018 A | — | 0 | 0 | $0 |
| Erik J. Verner | V.P., Chemistry Research | 12 Aralık 2018 A | — | 0 | 0 | $0 |
| Joseph J Buggy | EVP Discovery Research | 12 Aralık 2018 A | — | 0 | 0 | $0 |
| Jason V Coloma | SVP, Chief Business Officer | 08 Haziran 2016 A | — | 0 | 0 | $0 |
| David Scott Moore | Yönetim kurulu üyesi | 11 Haziran 2026 A | 21.700 | 1 | 0 | $250.201 |
| Richard Van Den Broek | Yönetim kurulu üyesi | 11 Haziran 2026 A | — | 0 | 0 | $0 |
| Linda S Grais | Yönetim kurulu üyesi | 11 Haziran 2026 A | — | 0 | 0 | $0 |
| Peter A. Thompson | Yönetim kurulu üyesi | 11 Haziran 2026 A | 210.000 | 0 | 0 | $0 |
| Ian T Clark | Yönetim kurulu üyesi | 11 Haziran 2026 A | — | 0 | 0 | $0 |
| Steve E. Krognes | Yönetim kurulu üyesi | 20 Haziran 2019 A | — | 0 | 0 | $0 |
| Scott W Morrison | Yönetim kurulu üyesi | 20 Haziran 2019 A | — | 0 | 0 | $0 |
| Terry P Gould | Yönetim kurulu üyesi | 20 Haziran 2019 A | 126.806 | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | Yönetim kurulu üyesi | 29 Mart 2016 C | 5.258.450 | 0 | 0 | $0 |
| Adams Street Partners, LLC | 10% sahip | 11 Ağustos 2022 A | 126.806 | 0 | 0 | $0 |
| Novo Holdings A/S | 10% sahip | 08 Temmuz 2020 S | 1.389.498 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Adams Street Partners, LLC, Adams Street 2011 Direct Fund LP, Adams Street 2012 Direct Fund LP, Adams Street 2013 Direct Fund LP, Adams Street 2014 Direct Fund LP, Adams Street 2015 Direct Venture/Growth Fund LP, Adams Street 2016 Direct Venture/Growth Fund LP, Adams Street 2017 Direct Venture/Growth Fund LP, Adams Street 2018 Direct Venture/Growth Fund LP, Adams Street Venture/Growth Fund VI LP ×2 başvurular | 05 Şubat 2026 | 3,90% | Değişiklik | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×13 başvurular | 27 Ocak 2026 | 10,30% | Değişiklik | — | SEC |
| Novo Holdings A/S ×2 başvurular | 09 Temmuz 2020 | — | İlk başvuru | — | SEC |
| Novo Holdings A/S (formerly known as Novo A/S) | 31 Ocak 2019 | — | İlk başvuru | — | SEC |
| Novo A/S | 30 Mart 2016 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 36 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1,95% | 165.305 NS | 31 Mayıs 2026 | N-PORT |
| BBC · ETFis Series Trust I | 1,34% | 32.976 NS | 30 Nisan 2026 | N-PORT |
| IDNA · iShares Trust | 0,96% | 137.099 SH | 08 Ağustos 2026 | Günlük |
| CANC · Tema ETF Trust | 0,76% | 108.477 NS | 31 Mayıs 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,66% | 86.347 NS | 31 Mayıs 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,35% | 121.201 NS | 30 Nisan 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 229.721 SH | 08 Ağustos 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 156.977 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 4.574 SH | 08 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,07% | 467.057 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 72.574 SH | 08 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,06% | 620.432 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,05% | 3.054 NS | 31 Mayıs 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 29.277 NS | 31 Mayıs 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,04% | 46.535 SH | 08 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 390.005 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,03% | 1.735.953 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,03% | 27.905 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 3.029 NS | 31 Mayıs 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 6.211 SH | 08 Ağustos 2026 | Günlük |
| ISCV · iShares Trust | 0,02% | 8.903 SH | 08 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | 0,01% | 2.886 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,01% | 2.369 NS | 31 Mayıs 2026 | N-PORT |
| SMLF · iShares Trust | 0,01% | 35.858 SH | 08 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,01% | 7.654 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 844.478 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 189.601 SH | 08 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 4.445 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,01% | 2.398 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 60 NS | 31 Mayıs 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 27.317 NS | 31 Mayıs 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.515 NS | 31 Mayıs 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 109.007 SH | 08 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 22.441 SH | 08 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.374.106 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.593 SH | 08 Ağustos 2026 | Günlük |